Product NDC: | 0641-0367 |
Proprietary Name: | Dexamethasone Sodium Phosphate |
Non Proprietary Name: | Dexamethasone Sodium Phosphate |
Active Ingredient(s): | 10 mg/mL & nbsp; Dexamethasone Sodium Phosphate |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0641-0367 |
Labeler Name: | West-ward Pharmaceutical Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA087702 |
Marketing Category: | ANDA |
Start Marketing Date: | 19820907 |
Package NDC: | 0641-0367-25 |
Package Description: | 25 VIAL in 1 CARTON (0641-0367-25) > 1 mL in 1 VIAL (0641-0367-21) |
NDC Code | 0641-0367-25 |
Proprietary Name | Dexamethasone Sodium Phosphate |
Package Description | 25 VIAL in 1 CARTON (0641-0367-25) > 1 mL in 1 VIAL (0641-0367-21) |
Product NDC | 0641-0367 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Dexamethasone Sodium Phosphate |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19820907 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp. |
Substance Name | DEXAMETHASONE SODIUM PHOSPHATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |